Fiscal Period | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
Issuance( Retirement)of Debt Net | -1,464.51 | 119.00 | 77.52 | 65.92 |
Net Changein Cash | -58.30 | 218.52 | 133.64 | 41.87 |
Cash Taxes Paid | 246.86 | 223.65 | 200.48 | 311.18 |
Net Income/ Starting Line | 971.35 | 727.23 | 747.21 | 972.55 |
Changesin Working Capital | -671.16 | -173.14 | -492.71 | -388.96 |
Cashfrom Operating Activities | 851.70 | 1,097.24 | 746.85 | 982.33 |
Cash Interest Paid | 128.68 | 208.18 | 178.56 | 155.32 |
Cashfrom Financing Activities | -813.96 | -164.21 | -145.40 | -151.85 |
Issuance( Retirement)of Stock Net | 779.23 | -12.58 | - | - |
Depreciation/ Depletion | 384.13 | 312.41 | 260.12 | 244.86 |
Other Investing Cash Flow Items Total | 312.93 | -405.38 | -64.32 | -391.80 |
Capital Expenditures | -406.93 | -307.13 | -403.36 | -396.99 |
period Type | - | - | - | - |
Foreign Exchange Effects | -2.05 | -2.00 | -0.13 | 0.19 |
Non- Cash Items | 167.38 | 230.74 | 232.23 | 153.89 |
Financing Cash Flow Items | -128.68 | -270.63 | -222.92 | -217.77 |
period Length | 12.00 | 12.00 | 12.00 | 12.00 |
Cashfrom Investing Activities | -94.00 | -712.51 | -467.69 | -788.79 |
Emcure Pharmaceuticals Dividend Emcure Pharmaceuticals Bonus Emcure Pharmaceuticals News Emcure Pharmaceuticals AGM Emcure Pharmaceuticals Rights Emcure Pharmaceuticals Splits Emcure Pharmaceuticals Board Meetings Emcure Pharmaceuticals Key Metrics Emcure Pharmaceuticals Shareholdings Emcure Pharmaceuticals Profit Loss Emcure Pharmaceuticals Balance Sheet Emcure Pharmaceuticals Q1 Results Emcure Pharmaceuticals Q2 Results Emcure Pharmaceuticals Q3 Results Emcure Pharmaceuticals Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks